Cargando…

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

BACKGROUND: Observational data and preliminary studies suggest serotonin 2A agonist psychedelics may hold potential in treating a variety of substance use disorders (SUDs), including opioid use disorder (OUD). AIMS: The study aim was to describe and analyze self-reported cases in which naturalistic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Romeu, Albert, Davis, Alan K., Erowid, Earth, Erowid, Fire, Griffiths, Roland R., Johnson, Matthew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987443/ https://www.ncbi.nlm.nih.gov/pubmed/32038317 http://dx.doi.org/10.3389/fpsyt.2019.00955

Ejemplares similares

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
por: Zamberlan, Federico, et al.
Publicado: (2018)

Corrigendum: The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports
por: Sanz, Camila, et al.
Publicado: (2018)

The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports
por: Sanz, Camila, et al.
Publicado: (2018)

The association between naturalistic use of psychedelics and co-occurring substance use disorders
por: Rabinowitz, Jonina, et al.
Publicado: (2023)

Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers
por: Boehnke, Kevin F., et al.
Publicado: (2023)

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
por: Phan, Angela N., et al.
Publicado: (2023)

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
por: Nayak, Sandeep M., et al.
Publicado: (2023)

Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States
por: Raison, Charles L., et al.
Publicado: (2022)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021)

Psychedelics and workplace harm
por: Viña, Sean Matthew, et al.
Publicado: (2023)

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
por: Zeifman, Richard J., et al.
Publicado: (2020)

Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey
por: Evens, Ricarda, et al.
Publicado: (2021)

Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study
por: Wojtalik, Jessica A., et al.
Publicado: (2016)

Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids
por: Bryan, M. Aryana, et al.
Publicado: (2021)

Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions
por: Huhn, Andrew S., et al.
Publicado: (2018)

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
por: Kurtz, Joshua S, et al.
Publicado: (2022)

Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020)

Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021)

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
por: Page, Lisa A., et al.
Publicado: (2021)

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
por: Yaden, David B, et al.
Publicado: (2021)

Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
por: Karoly, Hollis C., et al.
Publicado: (2020)

Cognitive Biases in Cannabis, Opioid, and Stimulant Disorders: A Systematic Review
por: Zhang, Melvyn W. B., et al.
Publicado: (2018)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
por: Langlitz, Nicolas, et al.
Publicado: (2021)

How Psychedelic-Assisted Treatment Works in the Bayesian Brain
por: Villiger, Daniel
Publicado: (2022)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
por: Mosurinjohn, Sharday, et al.
Publicado: (2023)

Medical student attitudes and perceptions of psychedelic-assisted therapies
por: Li, Irene, et al.
Publicado: (2023)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
por: Close, James B., et al.
Publicado: (2021)

Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States
por: Avram, Mihai, et al.
Publicado: (2021)

Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
por: Neuhaus, Edmund C., et al.
Publicado: (2022)

Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
por: Mintz, Kevin T., et al.
Publicado: (2022)

Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity
por: Fischman, Lawrence G.
Publicado: (2022)

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
por: Ko, Kwonmok, et al.
Publicado: (2022)

Classic psychedelics do not affect T cell and monocyte immune responses
por: Rudin, Deborah, et al.
Publicado: (2023)

Can Psychiatry be Misused Again?
por: Sfera, Adonis
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jvl63svlajp17cj9odsqtcue1s